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I sit in my office at 5:00 pm when a colleague rings 
to tell me that a young woman with enterohemor-
rhagic Escherichia coli (EHEC)-associated hemo-
lytic uremic syndrome (HUS) has arrived in the 
emergency department and that he wanted to 
double-check whether it was okay to put her on 
immediate plasmapheresis this evening. Consid-
ering her really bad lab results and the fact that 
she had been to the emergency department on 12 
May complaining of bloody diarrhea, it seems the 
right thing to do even though the recommenda-
tion for EHEC-associated HUS usually includes 
only symptomatic therapy.
19 May
In the morning my colleague rings again to 
inform me that another young woman with 
EHEC-associated HUS was brought to the ICU 
overnight. We put her on plasmapheresis too, 
and discuss this unusual situation. In the evening 
I notify the director of the hospital that we are 
prepared for the weekend.
20 May
Five new patients with HUS in the emergency 
department. By now it is clear: this is more seri-
ous than we all thought. One colleague talks to our 
pediatric nephrology department and learns that 
five children with HUS are currently being treated 
there. Some have severe neurological symptoms 
and are being treated with plasmapheresis. Other 
hospitals in Hamburg also report HUS patients. 
At 6:00 pm all nephrology consultants meet with 
an epidemiologist from the Robert Koch Institute 
(RKI), the national institute responsible for dis-
ease control, who has collected food histories in 
the pediatric nephrology department and in other 
hospitals in northern Germany during the past 
days. Apparently the EHEC infection does not 
seem to be associated with meat or dairy products. 
Hints rather point toward vegetables or fruit.
21 May
Together with two epidemiologists from the 
RKI, I walk around the hospital all day to take 
food histories from the HUS patients. All HUS 
patients who are able to talk agree to answer the 
25-page food questionnaire.
22 May
Sunday. The RKI people would like to perform a 
case-control study with healthy people from the 
neighborhoods with the same area code as the 
HUS patients, and need help with the protection 
of data privacy to do their job. This is beyond my 
authority, so I ask the RKI people to talk with the 
authorities of the public-health department and 
the director of the hospital. An hour later he calls 
me and asks whether I think this is serious. “It’s 
incredibly serious,” I say.
23 May
Over the weekend five new HUS patients have 
arrived in our hospital. Several media outlets 
have started to report the EHEC outbreak in 
their online editions over the weekend, and 
today many printed newspapers cover the 
topic. We learn from our gastroenterology col-
leagues that several EHEC patients without 
HUS have been admitted to their ward and are 
being treated with polyethylene glycol colon-
oscopy preparation solution with the intention 
of cleaning the colon of EHEC faster. With the 
president of the German Society of Nephrology 
we discuss organizing a special EHEC informa-
tion page on the society’s website. At the end 
of the day, seven new adults have been admit-
ted with HUS, and 18 adults are being plasma-
separated per day. What scares us most is the 
increasing number of patients who are very 
weak and seem to develop amnesic aphasia.
24 May
The hospital installs a crisis squad of the chiefs 
of involved departments (nephrology, pediatric 
nephrology, gastroenterology, hygiene, micro-
biology, intensive care, emergency, transfusion 
medicine, neurology, psychology) that meets 
once a day to coordinate whatever is needed. 
The RKI people are back with another question-
naire that investigates only nine food items that 
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remain suspicious after the case control study. 
There are first hints that the EHEC seems not to 
be the ‘usual’ O157 strain but rather the serotype 
O104:H4 (ref. 1) and in addition seems to pro-
duce extended-spectrum b-lactamase (ESBL). 
We discharge all remaining non-HUS nephrol-
ogy patients to make more ward space available 
for the isolation of the increasing number of HUS 
patients (27 will be on my list in the evening). For 
the first time since the epidemic started, EHEC 
makes it into the 8 o’ clock prime-time news on 
TV channel one.
25 May
The RKI gives out a warning that the case-control 
study conducted in Hamburg suggests an 
asso c iation between the occurrence of disease 
and the consumption of raw tomatoes, cucum-
ber, and leaf salad.2 The gastroenterologists have 
opened a special outpatient clinic where they see 
only patients with (bloody) diarrhea—about 120 
a day. Two nephrology wards and one ICU ward 
are filled with HUS patients in all states of the 
disease, many of them with severe neurologi-
cal symptoms, including seizures. Most patients 
are between 20 and 50 years old, and one nurse 
speaks out loud what we are all thinking: “It could 
be me lying in this bed.” Volunteer dialysis staff 
is recruited from other departments and from 
other parts of Germany, and the dialysis residents 
plus three residents from our department who 
were doing a research rotation develop a three-
shift model to care for everybody. Eight more 
machines for plasmapheresis are delivered. We 
give out a departmental note that plasmapheresis 
has to be carried out on the wards and not in the 
dialysis unit (which we need to perform dialyses), 
and one nurse is allowed to treat two patients in 
the same room at a time. The situation is under 
control, but nobody knows for how long.
26 May
The day starts with amazing news: the New 
England Journal of Medicine released an ahead-
of-print publication yesterday reporting the 
improvement of three 3-year-old children with 
severe Shiga-toxin-associated HUS after treat-
ment with the monoclonal C5 antibody ecu-
lizumab.3 This looks like a possible treatment 
option for many of our patients who do not seem 
to respond to plasmapheresis or whose neuro-
logical symptoms deteriorate despite treatment. 
We start talking to the company about possible 
off-label use of eculizumab and to the president 
of the German Society of Nephrology about 
designing a treatment-protocol suggestion for the 
society’s website. More news at midday: EHEC 
was detected on cucumbers from Spain, reports 
Hamburg’s state secretary of health at a press con-
ference. Nobody knows yet that the serotype that 
is going to be found on these cucumbers will not 
be O104:H4. The cucumber information will lead 
to great economic losses for Spanish farmers and 
quarrels between the European Union countries. 
At the end of the day we—and the other hospi-
tals in Hamburg—have reached our full capacity 
for HUS patients, which means I have to transfer 
three patients to Hanover.
27 May
Several HUS patients can be discharged today—
a big relief to everyone. Two women, 81 and 87 
years old, have died, though, and the number 
of HUS admissions is still increasing. We need 
more beds and dialysis personnel, and, miracu-
lously, it all works out. Everyone is doing a great 
job in teams that have never worked together 
before. With a preliminary protocol, nine HUS 
patients receive their first dose of eculizumab.
28 and 29 May
In retrospect this is the worst weekend of 
my entire professional life. Most depress-
ing is the increasing number of patients with 
neuro logical deterioration from headache via 
amnesic aphasia, cognitive deficits, pareses, and 
myoclonic seizures to epileptic status that can 
be broken only by analgosedation. At the end 
of the weekend a total of 85 HUS patients are 
on my list, including six pregnant women and 
22 patients in the ICU, most of them ventilated. 
Fifteen patients have received eculizumab, and 
I had to send three more patients to Hanover 
and one to Berlin. We have performed 42 plas-
maphereses per day and about 20 dialyses.
30 May and thereafter
We learn that plasma stocks in northern Germany 
are decreasing rapidly and more blood donations 
are needed. Discussions about a final protocol for 
eculizumab therapy between the German Soci-
ety of Nephrology and the company carry on. 
The number of patients going into renal failure 
increases dramatically, though, and we have to 
order five more dialysis machines to be able to 
dialyze every patient who needs this treatment.
2 June and thereafter
Eventually many patients improve, but although 
most of them are young, they are still too weak to 
be sent home. The current HUS data for the whole 
of Germany are published by the RKI.4 It’s a great 
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relief to us that many patients with severe neuro-
logical symptoms are slowly improving. Sprouts 
from a farm in Lower Saxony are under suspicion 
of having been contaminated with EHEC, accord-
ing to a press conference given by the state secre-
tary of agriculture of Lower Saxony.
21 June
While I am writing this diary my colleague mails 
the latest data: 137 HUS patients have been treated 
so far in our department; four have died, 41 are still 
on the wards, 62 have been treated with eculizumab. 
It will require a long period of follow-up before we 
know who is really well again. And one thing is for 
sure: eating will never be the same again.
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